Conference title: “Clinical & Translational Research in Pneumonia:
Defining a Research Agenda for Today and Tomorrow”

Introduction

The NIH Research Conference Grant (R13) supports high quality scientific conferences in areas that are important to the NIH's mission and to the public health. We just received notification that the National Heart, Lung, and Blood Institute (NHLBI) has approved the application for an international research conference entitled: “Clinical & Translational Research in Pneumonia: Defining a Research Agenda for Today and Tomorrow”. The conference will be held on Wednesday, May 24th and Thursday, May 25th, 2017 in the city of Washington, D.C., USA following the 2017 ATS Annual Meeting at the National Union Building, 918 F Street NW.

To register for the conference online click here. For additional information regarding the conference, please contact Kim Buckner, Conference Coordinator at kim.buckner@louisville.edu. We look forward to seeing you there.

Sincerely,

Julio Ramirez, MD
Conference Chair

Julio Ramirez, MD

Richard Wunderink, MD
Conference Co-chair

Richard Wunderink, MD

Charles Feldman, MD
Conference Co-chair

Charles Feldman, MD

Conference Summary

Lung infections are a leading cause of infectious disease-related death worldwide. Generation of new knowledge in all aspects of lung infections such as prevention and treatment is critical to decreased morbidity and mortality.

Current international medical conferences are good venues for the transfer of knowledge from experts in the field to a general audience of practitioners. On the other hand, opportunities for researchers to have the appropriate time and setting to discuss their current research and gain feedback and collaboration are limited. Although virtual meetings allow investigators to interact, the outcomes of these interactions are rarely equal to in-person contact.

The existing paradigm for scientific conferences is to allow the presenter approximately 45 minutes to outline a detailed description of her/his research including completed work that may have been already published. This is traditionally followed by 15 minutes of questions focused on clarifying concepts from the presentation.

In this conference we are challenging this existing paradigm. The presentations will be more focused, last only 15-minutes, and exclude detailed of previous literature of the topic. It will be followed not by a question and answer session, but by a 15-minute moderated brainstorming session. This brainstorming will allow for a free flow of ideas from all of the experts. Some presentations will focus on “defining the research agenda for today” and some on “defining the research agenda for tomorrow.”

Speakers in the module “defining the research agenda for today” will have 15 minutes to present the most important aspects of her/his active research activities with limited discussion of already published data and background information. The presentation will be followed by a 15 minute moderated brainstorming session to give expert feedback and to generate new ideas for collaboration.

Speakers in the module “defining the research agenda for tomorrow” will have 15 minutes to present the most important research gaps in a particular field of pneumonia. The presentation will be followed by a 15 minute moderated brainstorming session to generate pathways for resolution of current gaps.

Conference Objectives

The overall objective of the conference is to bring together the pneumonia research community to provide a unique opportunity to foster global clinical and translational research in the field of pneumonia, influenza, and emerging respiratory pathogens.

To achieve this, the conference has the following objectives:

  1. To foster an international research network in the field of pneumonia, influenza, and emerging respiratory pathogens.
  2. To expand and strengthen the existing research collaboration among national and international investigators.
  3. To recognize gaps in the knowledge of lung infections and to identify research pathways to fill these gaps.
  4. To engage junior investigators in the field of lung infection research.

We expect the following measurable outcomes to occur during this meeting and the following year:

  1. A published symposium proceedings in The University of Louisville Journal of Respiratory Infections http://louisville.edu/jri.
  2. A live stream of the conference enabling virtual participation for those unable to attend in Washington, D.C.
  3. YouTube videos of the conference.
  4. The development of at least three new international research projects.
  5. Monthly follow-up virtual meetings utilizing conferencing software (e.g., GoToMeeting).
  6. The continued development of an international group of experienced investigators available to mentor junior investigators.

All aspects of this research symposium will be managed by the University of Louisville Clinical Research Support Program (louisville.edu/research-support).

Conference Plan

Significance

Importance of the problem: According to data from the World Health Organization, lower respiratory tract infections, such as pneumonia, influenza, and emerging respiratory pathogens, are the leading cause of infectious disease-related death worldwide (1). Clinical and translational research is critical to decrease morbidity and mortality associated with these respiratory infections. One crucial impediment to international collaborative research is the lack of forums for investigators to network and generate effective research partnerships.

This research conference would have a significant impact in the area of pneumonia, influenza, and emerging respiratory pathogens through:

  1. Development of a team of experts from around the globe who will strengthen the capacity to conduct research in respiratory infections.
  2. Development of an international team of researchers who will contribute to science and impact public health policy.
  3. Establishment of support for training-related research that is directly relevant to respiratory tract infections, one of the health priorities outlined in Healthy People 2020.

Innovation

The research conference has the following innovative approaches:

  1. Assembling leading investigators representing almost all well-established lung infection research sites from around the world.
  2. A full day dedicated to current and future research ideas in the fields of pneumonia, influenza and emerging respiratory pathogens.
  3. A fifteen-minute presentation by each leading investigator, focusing on current and future research projects.
  4. A fifteen-minute brainstorming session following each presentation, focusing on the exchange of ideas surrounding the prior presentation.
  5. A YouTube channel to host the videos of each presentation and brainstorming session, freely accessible to all interested parties.
  6. Providing a free live stream to enable virtual participants unable to attend in person.
  7. Providing a sustained collaborative environment using monthly virtual meetings to promote continued investigator engagement.
  8. The development of a group of experienced investigators available to mentor junior investigators across international sites.
  9. Support the mentoring process through the use and availability of virtual connections enabling on-demand connection between mentor and mentee.

Directors and Administrators

This research conference will be chaired by Dr. Julio Ramirez, Professor of Medicine at the University of Louisville. The conference co-chairs will be Dr. Richard Wunderink, Professor of Medicine at Northwestern University and Dr. Charles Feldman, Professor of Pulmonology at the University of the Witwatersrand.

The University of Louisville Clinical Research Support Program will be responsible for the following aspects of this conference:

  1. Preconference planning and communication
  2. Conference management and logistics
  3. Post conference evaluation
  4. Coordination of manuscript preparation
  5. Multimedia development and distribution
  6. Management of monthly virtual conference
  7. Coordination of the virtual mentorship program

The primary members of the Clinical Research Support Program participating in this project will include: Dr. Paula Peyrani, Dr. Timothy Wiemken, Dr. William Mattingly, Ms. Kimberley Buckner.

Conference Speakers

We are pleased that all of the following speakers, representing national and international pneumonia research teams, have agreed to present their current research projects during the conference:

Speakers Representing Research Teams from the United States

Richard Wunderink, MD
Professor of Medicine
Pulmonary and Critical Care
Northwestern University
Chicago, USA
Michael S Niederman, MD
Professor of Clinical Medicine
Joan and Sanford I. Weill Department of Medicine
Weill Cornell University
New York, New York, USA
Thomas File, MD
Professor of Medicine
Northeastern Ohio Universities
Chief, Infectious Disease Service
Summa Health System
Akron, USA
Julio Ramirez, MD
Professor of Medicine
Chief, Division of Infectious Diseases
University of Louisville
Louisville, USA
Paula Peyrani, MD
Assistant Professor of Medicine
Assistant Director, Clinical Research Support Program
Division of Infectious Diseases
University of Louisville
Louisville, USA
Stephen Furmanek, MPH
Research Analyst, Senior
Clinical Research Support Program
Division of Infectious Diseases
University of Louisville
Louisville, USA
Nathan C. Dean, MD
Professor of Medicine
Chief, Pulmonary and Critical Care
Intermountain Medical Center
University of Utah
Salt Lake City, USA
Marcos Restrepo, MD
Associate Professor Medicine
Director, Intensive Care Unit,
Audie L Murphy Veterans Hospital
University of Texas
San Antonio, USA
Mark Metersky, MD
Professor of Medicine
Medical Director, UConn Center for Bronchiectasis Care
Director, Pulmonary and Critical Care Fellowship Program
University of Connecticut
Farmington, Connecticut, USA
Charles Dela Cruz, MD
Associate Professor of Medicine
Director, Yale Center for Pulmonary Infection Research and Treatment (CPIRT)
Yale University
New Haven, Connecticut, USA
Jose Bordon, MD
Assistant Professor
Georgetown University
Chief, Section of Infectious Diseases
Providence Hospital
Washington, DC, USA
Daniel Musher, MD
Distinguished Service Professor of Medicine-Infectious Disease
Baylor College of Medicine
Houston, Texas, USA
Lis Caler, Ph.D.
Program Director, Division of Lung Diseases
National Heart, Lung, and Blood Institute
NIH
Bethesda, Maryland, USA
Barbara Jones, MD
Assistant Professor, Pulmonary/Critical Care Medicine
Salt Lake City Veterans Affairs Medical Center
University of Utah
Salt Lake City, Utah, USA

Speakers Representing Research Teams from Other Countries

Tobias Welte, MD
Professor of Pulmonary Medicine
Head, Department of Pulmonary & Infectious Diseases
Hannover University
Hannover, Germany
Antoni Torres, MD
Professor of Medicine
Director of Institut Clínic de
Pneumologia i Cirurgia Toràcica
Hospital Clínic de Barcelona
Barcelona, Spain
Jordi Rello, MD
Associate Professor of Medicine
Chief of Critical Care
Vall d’Hebron University Hospital
University of Barcelona
Barcelona, Spain
James Chalmers, MD
Lecturer in Respiratory Medicine
Department of Respiratory Medicine
Ninewells Hospital and Medical School
Dundee, Scotland
Stefano Aliberti, MD
Department of Health Science
University of Milan-Bicocca
Respiratory Dept, AO San Gerardo
Monza, Italy
Rosario Menedez, MD
Chief, Pneumology Department
Hospital La Fe
Valencia, Spain
Grant Waterer, MD
Professor of Medicine
Medical Co-Director, Service 4
Royal Perth Hospital
University of Western Australia
Perth, Australia
Charles Feldman, MD
Professor of Pulmonology
Chief Physician, Charlotte Maxeke
Johannesburg Academic Hospital
University of the Witwatersrand
Johannesburg, South Africa
Carlos Luna, MD
Professor of Medicine
Chief, Pulmonary Hospital Clínicas
Universidad de Buenos Aires
Buenos Aires, Argentina
Yuichiro Shindo, MD
Associate Professor of Medicine
Department of Respiratory Medicine
Nagoya University
Nagoya, Japan
Otavio Ranzani
Research Fellow
Respiratory and Critical Care, Hospital Clinic
Universitat de Barcelona
Barcelona, Spain

Registration

Conference Dates, Hours, and Location

The research conference will take place on Wednesday, May 24th from 9AM until 6PM and on Thursday, May 25th from 8AM until 4PM. The conference will take place at The Loft at 918 F Street NW, Washington, D.C. 20004.

Conference Participants & Registration

This conference is open to all healthcare workers interested in the field of pneumonia research. If you are interested in participating in this conference, please complete the registration form to be registered as a conference participant.

Virtual Participant

We are planning to offer this research conference on a free online platform to allow interested investigators to be a virtual participant in the conference. For more information please complete the registration form requesting to be registered as a conference virtual participant.

Conference Proceedings

The University of Louisville Journal of Respiratory Infections will offer a published conference proceedings supplement summarizing the current and future areas of research from each of the participating research centers, which will be available at http://louisville.edu/jri.

© 2014-2017 Clinical Research Support Program (CRSP). All rights reserved.